Board of Governors
Founder & CEO, Royalty Pharma
Pablo Legorreta is the Founder and CEO of Royalty Pharma. Formed in 1996, Royalty Pharma is the industry leader in acquiring revenue-producing intellectual property, with over $12 billion in assets. Royalty Pharma funds innovation in life sciences, indirectly, when it acquires existing royalty interests from the original innovators (academic institutions, research hospitals, foundations and inventors) or, directly, when it partners with life sciences companies to co-develop and co-fund products in late-stage human clinical trials. Royalty Pharma is a rapidly growing biopharmaceutical company with revenue and EBITDA in 2014 of $1.97 billion and $1.94 billion, respectively.
Prior to Royalty Pharma, Mr. Legorreta had a 10 year career as an M&A banker at Lazard Frères - from 1987 to 1990 at Lazard Frères et Cie (Paris) and from 1990 to 1996 at Lazard Frères & Co. (New York). Mr. Legorreta currently serves as a Director of Giuliani S.p.A., Atentiv, and Médica Sur. He serves on the Boards of Trustees of Pasteur Foundation (U.S. affiliate of the French Institut Pasteur), The Open Medical Institute, The Allen-Stevenson School and The Park Avenue Armory. Mr. Legorreta founded and is currently Chairman of Alianza Médica para la Salud, a privately-funded, not-for-profit foundation whose goal is to educate Latin American doctors and healthcare providers. Mr. Legorreta received a degree in industrial engineering from Universidad Iberoamericana.